RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
5.03
+0.15 (3.07%)
Oct 21, 2026, 2:16 PM EDT - Market open
RxSight Market Cap
RxSight has a market cap or net worth of $209.21 million as of October 21, 2026. It is the 20,640th most valuable company in the world and the 3,558th biggest in the United States. Its market cap has decreased by 40.06% in one year.
Market Cap
209.21M
Enterprise Value
11.00M
1-Year Change
-40.06%
Global Rank
Country Rank
#3,558 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $209.21M, a decrease of -50.70%. That is a compound annual growth rate of -12.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 209.21M | -51.17% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InfuSystem Holdings | 282.82M |
| Treace Medical Concepts | 264.04M |
| Perspective Therapeutics | 263.69M |
| Quantum-Si incorporated | 256.09M |
| Standard BioTools | 251.80M |
| Electromed | 227.73M |
| TriSalus Life Sciences | 225.36M |
| Profound Medical | 214.30M |